Biotech entity
Every one of those 1 sits in a single category, pharma. Chris Chen is most often covered alongside European Medicines Agency (EMA), which appears in 1 of these 1 story. The tracked stories average 2 original sources each. Chris Chen appears in 1 tracked Biotech story from June 18, 2026.
Last mentioned: Jun 18, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, pharma. Chris Chen is most often covered alongside European Medicines Agency (EMA), which appears in 1 of these 1 story. The tracked stories average 2 original sources each. Chris Chen appears in 1 tracked Biotech story from June 18, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 2 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Chris Chen. Shared-story counts are live from our verified record — not editorial picks.
With zero critical findings on its fourth EMA GMP certification, WuXi Biologics now empowers 13 biotech clients to commercialize 19 biologics in Europe. This milestone validates the company's integrated CRDMO model and deepens its competitive moat in the biologics CDMO space.
Source: prnewswire.com · pannaphat.me
Chris Chen is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
